Ulcerative colitis in a southern european country: A national perspective

Inflammatory Bowel Diseases

Volumn 16, Issue 5, 2010, Pages 822-829

  Portela, Francisco ^a,b,r   Magro, Fernando ^a,c,d   Lago, Paula ^a,e   Cotter, José ^a,f   Cremers, Isabelle ^a,g   De Deus, João ^a,h   Vieira, Ana ^a,i   Lopes, Horácio ^a,j   Caldeira, Paulo ^a,k   Barros, Luísa ^a,l   Reis, Jorge ^a,m   Carvalho, Laura ^a,n   Gonçalves, Raquel ^a,o   Campos, Mario J ^a,b   Ministro, Paula ^a,p   Duarte, Maria A ^a,q   Amil, Jorge ^a,c   Rodrigues, Susana ^a,c   Azevedo, Luís ^a,d   Costa Pereira, A ^a,d  

^a Portuguese Study Group of Inflammatory Bowel Diseases (GEDII)   (Portugal)

^b CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^c Hospital de so João   (Portugal)

^d University of Porto   (Portugal)

^e HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^f Centro Hospitalar do Alto Ave ^*  (Portugal)

^g Hospital de S Bernardo   (Portugal)

^h Department of Psychiatry   (Portugal)

ⁱ HOSPITAL GARCIA DE ORTA   (Portugal)

^j Hospital das Caldas da Rainha   (Portugal)

^k Hospital   (Portugal)

^l Servicio de Neurología Centro Hospitalar do Tâmega e Sousa Unidade Padre Américo   (Portugal)

^m HOSPITAL PULIDO VALENTE   (Portugal)

ⁿ Hospital de Vila Real   (Portugal)

^o Hospital S Marcos   (Portugal)

^p Hospital S Teotonio   (Portugal)

^q HOSPITAL DO DIVINO ESPÍRITO SANTO   (Portugal)

^r UNIVERSITY OF COIMBRA   (Portugal)

more..

Author keywords

Follow up; Medical treatment; Relapse; Surgery; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MERCAPTOPURINE; METHOTREXATE; PREDNISOLONE; SALICYLIC ACID; STEROID;

ABDOMINAL SURGERY; ADULT; ANUS SURGERY; ARTICLE; COLON RESECTION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; EUROPE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; ONLINE SYSTEM; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROCTITIS; PROCTOCOLECTOMY; REGISTER; REMISSION; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COLITIS, ULCERATIVE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PORTUGAL; PREVALENCE; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 77950651609     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21119     Document Type: Article

References (24)

1. 1. Shivananda S, Lennard-Jones J, Logan R, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996; 39: 690-697. (Pubitemid 26426470)
2. Tragnone A, Corrao G, Miglio F, et al. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Gruppo Italiano per Io Studio del Colon e del Retto (GISC). Int. J Epidemiol. 1996; 25:1044-1.052.
3. Magro F, Portela F, Lago P, et al. A Pharmaco-epidemiological. approach to estimate IBD prevalence and incidence in Portugal. J Crohn's Colitis. 2008; 2:35.
4. 4. Tavarela Veloso F, Fraga J, Carvalho J. Inflammatory bowel disease in Oporto. A prospective hospital study. Scand J Gastroenterol Suppl. 1989; 170:32-35 (Pubitemid 20015819)
5. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989; 170:2-6.
6. 6. Satsangi. J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut, 2006; 55:749-753. (Pubitemid 43764536)
7. 7. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther. 2002; 16:51-60. (Pubitemid 34123864)
8. Gower-Rousseau C, Salomez. JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut. 1994; 35: 1433-1438.
9. 9. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003; 143:525-531. (Pubitemid 37352514)
10. Polito JM, 2nd, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM, Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology. 1996; 111: 580-586.
11. 11. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease; controversies, consensus, and implications. Gut. 2006; 55;749-753. (Pubitemid 43764536)
12. Hole O, Wolters F, Riis L, et al. European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD). Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a Europeanwide population-based cohort. Am J Gastroenterol. 2007; 102: 1692-1701.
13. Mourn B, Ekbom A, Vatn MH, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-1993. Scand J Gastroenterol. 1997; 32: 1005-1012.
14. 14. Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001; 120:13-20. (Pubitemid 32061864)
15. 15. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci, 1989; 34:1841-1854. (Pubitemid 20018648)
16. 16. Mokbel M, Carbonnel F, Beaugerie L, et al, Effect of smoking on the long-term course of ulcerative colitis. Gastroenterol. Clin Biol. 1998; 22:858-862. (Pubitemid 28559705)
17. 17. Aldhous MC, Drummond HE, Anderson N, et al. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol. 2007;102:589-597. (Pubitemid 46328159)
18. 18. Park SH, Kim. YM, Yang SK, et al. Clinical, features and natural history of ulcerative colitis in Korea. Inflamm Bowel Dis. 2007;13: 278-283. (Pubitemid 46465908)
19. 19. Ho GT, Chiam P, Drummond H, et al. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther. 2006;24:319-330 (Pubitemid 43972900)
20. 20. Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: Analysis of changes in disease activity over years. Gastroenterology. 1994;107:3-11. (Pubitemid 24195339)
21. Selby W. The natural history of ulcerative colitis. Baillieres Clin Gastroenterol. 1997;11:53-64.
22. 22. Stewenius J, Adnerhill I, Ekelund GR, et al. Risk of relapse in new cases of ulcerative colitis and indeterminate colitis. Dis Colon Rectum. 1996;39:1019-1025. (Pubitemid 26304985)
23. 23. Henriksen M, Jahnsen J, Lygren I, et al. IBSEN Study Group. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006;12: 543-550. (Pubitemid 43977734)
24. Hoie O, Wolters FL, Riis L, et al. European Collaborative Study Group of Inflammatory Bowel Disease. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology. 2007;132:507-515.